4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-017325
Chief Financial Officer sold 300 shares at $10.00 ($3,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-06-12 | Sale 10b5-1 | −300 | $10.00 | $3,000 | 101,817 | D |
| Open-market sales · 300 sh · avg $10.00 · $3,000 | |||||||
Loading xslF345X05/form4-06132025_110620.xml…